Nitisinone Oral Suspension and Prednisone Intensol
Determining the interaction of Nitisinone Oral Suspension and Prednisone Intensol and the possibility of their joint administration.
In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.
Consumer:Consumer information for this interaction is not currently available.MONITOR: Coadministration with inducers of CYP450 3A4 may decrease the plasma concentrations and therapeutic effects of nitisinone. The proposed mechanism is induction of CYP450 3A4-mediated metabolism of nitisinone, which has been shown in vitro to be metabolized by this isoenzyme. However, data evaluating the interaction are not available. MANAGEMENT: Until more information is available, caution is advised if nitisinone is used concomitantly with CYP450 3A4 inducers. Dosage adjustments as well as clinical and laboratory monitoring of nitisinone should be considered whenever a CYP450 3A4 inducer is added to or withdrawn from therapy. References Canadian Pharmacists Association "e-CPS. Available from: URL: http://www.pharmacists.ca/function/Subscriptions/ecps.cfm?link=eCPS_quikLink." Cerner Multum, Inc. "Australian Product Information." O 0 Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0
Professional:MONITOR: Coadministration with inducers of CYP450 3A4 may decrease the plasma concentrations and therapeutic effects of nitisinone. The proposed mechanism is induction of CYP450 3A4-mediated metabolism of nitisinone, which has been shown in vitro to be metabolized by this isoenzyme. However, data evaluating the interaction are not available.
MANAGEMENT: Until more information is available, caution is advised if nitisinone is used concomitantly with CYP450 3A4 inducers. Dosage adjustments as well as clinical and laboratory monitoring of nitisinone should be considered whenever a CYP450 3A4 inducer is added to or withdrawn from therapy.
- Canadian Pharmacists Association "e-CPS. Available from: URL: http://www.pharmacists.ca/function/Subscriptions/ecps.cfm?link=eCPS_quikLink."
- Cerner Multum, Inc. "Australian Product Information." O 0
- Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0
Generic Name: nitisinone
Brand name: Orfadin, Nityr
Synonyms: Nitisinone
Generic Name: prednisone
Brand name: Rayos, Sterapred, Deltasone
Synonyms: Prednisone, PredniSONE
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Nitisinone Oral Suspension-Prednisone Oral Concentrate
- Nitisinone Oral Suspension-Prednisone Oral Solution
- Nitisinone Oral Suspension-Prednisone Tablets
- Nitisinone Oral Suspension-PreferaOB
- Nitisinone Oral Suspension-PreferaOB (Prenatal Vitamin Without Vitamin A)
- Nitisinone Oral Suspension-PreferaOB (Vitamins (Multiple/Prenatal))
- Prednisone Intensol-Nitisinone Tablets
- Prednisone Intensol-Nitrek
- Prednisone Intensol-Nitric Oxide
- Prednisone Intensol-Nitric oxide Inhalation
- Prednisone Intensol-Nitric oxide inhalation gas
- Prednisone Intensol-Nitro TD Patch-A transdermal